A Best Practice Guide to Managing Non-CRF Data

How to overcome the challenges of reconciling external data

With over 70% of clinical study data originating from different vendors, manual processes like validation and issue management can compromise quality and cause delays. Our best practice guide gives you a step-by-step approach to combat these delays and improve the quality and compliance of third party deliverables.

What you’ll learn

How to reduce study timelines and resources needed to reconcile your external vendor data

How to streamline the number of systems you’re working with, including sFTPs, different portals for vendor delivery and communication tools

How P21 Data Exchange can meet all your external data reconciliation needs

About the author

Erin Erginer

Director of Product

Innovative leader with 20 years of clinical research and healthcare experience, specializing in acquisition, management, and transformation of clinical biospecimen and digital health assessment data. Collaborative creator of tech-enabled solutions for the pharmaceutical industry.

Download the guide

Submit the form below to learn how to best handle non-CRF data reconciliation!

About Certara

Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.

From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.